Monster Energy Team Claims 13 Medals (4 Gold, 4 Silver, 5 Bronze) at X Games Osaka 15-Year-Old Arisa Trew from Australia, Claims Double Gold in Women's...
31-Year-Old Troy Brosnan from Adelaide, South Australia, Takes 2nd Place in Elite Men Division24-Year-Old Thibaut Daprela from France Claims 3rd Place
VAL DI SOLE, Italy,...
-15-Year-Old Arisa Trew from Palm Beach, Australia, Claims Gold in Women's Skateboard Vert, Ties All-Time Record for Most X Games Gold Medals in Women's...
Renowned Artist and John Wayne Airport Art Commissioner Targeted in Sophisticated Heist
ANAHEIM, Calif., June 20, 2025 /PRNewswire/ -- Two monumental sculptures by internationally recognized...
TORONTO and HAIFA, Israel, June 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biotech company developing exosome-based therapies for central nervous system injuries, announced today that it has been accepted into the HealthTech Hub (“HTH”) Accelerator Program. Based in Boston, Massachusetts, home to more than 1,000 biotech companies1, HTH is operated by the Advanced Regenerative Manufacturing Institute (“ARMI”) and its BioFabUSA initiative.
SHANGHAI, June 20, 2025 /PRNewswire/ -- During the recent 2025 SNEC exhibition in Shanghai, LONGi, a global leader in PV technology innovation, signed a strategic...
In a May 2025 appearance on Morningstar's The Long View podcast, Wall Street Journal columnist Jason Zweig provided crucial insights for investors facing significant...
RS offers an extensive selection of Festo process automation products engineered to improve efficiency, safety, productivity, profitability, and product quality in industrial fluid process...
DALLAS, June 18, 2025 /PRNewswire/ -- The military community's hard-earned Army & Air Force Exchange Service benefit paid off in 2024 as shoppers generated...
MELVILLE, N.Y., June 18, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, is pleased to announce that its Chief Executive Officer, Lance Alstodt, will be interviewed during the Benzinga All-Access Show today, Wednesday, June 18, 2025, at 10:50 a.m. Eastern time.